The two sector indices - SXI LIFE SCIENCES® and SXI Bio+Medtech® give the industry greater
visibility in the financial market and have a positive impact on liquidity.
The SXI LIFE SCIENCES® index comprises
companies from the pharmaceutical, biotechnology and medical technology areas, while its sub-index - the
SXI Bio+Medtech® - focuses solely on bio- and
medtech companies. Both indices open to Swiss and foreign companies alike and since their initial calculation
in December 1999 have turned in impressive performances in an international comparison. The maximum weighting of any
given stock is limited to 10%, which gives greater prominence to small- and medium-sized
companies. Index inclusion is possible from day one, raising your companys profile right after listing.